145 related articles for article (PubMed ID: 9489430)
1. [The effect of heparin on release of histamine from basophils under the influence of MCAF/MCP-I in patients with bronchial asthma].
Antczak-Marczak M; Kuna P
Pneumonol Alergol Pol; 1997; 65(9-10):581-7. PubMed ID: 9489430
[TBL] [Abstract][Full Text] [Related]
2. RANTES, a monocyte and T lymphocyte chemotactic cytokine releases histamine from human basophils.
Kuna P; Reddigari SR; Schall TJ; Rucinski D; Viksman MY; Kaplan AP
J Immunol; 1992 Jul; 149(2):636-42. PubMed ID: 1378073
[TBL] [Abstract][Full Text] [Related]
3. Characterization of the human basophil response to cytokines, growth factors, and histamine releasing factors of the intercrine/chemokine family.
Kuna P; Reddigari SR; Schall TJ; Rucinski D; Sadick M; Kaplan AP
J Immunol; 1993 Mar; 150(5):1932-43. PubMed ID: 7679699
[TBL] [Abstract][Full Text] [Related]
4. Monocyte chemotactic and activating factor is a potent histamine-releasing factor for basophils.
Alam R; Lett-Brown MA; Forsythe PA; Anderson-Walters DJ; Kenamore C; Kormos C; Grant JA
J Clin Invest; 1992 Mar; 89(3):723-8. PubMed ID: 1371775
[TBL] [Abstract][Full Text] [Related]
5. Chemokines of the alpha, beta-subclass inhibit human basophils' responsiveness to monocyte chemotactic and activating factor/monocyte chemoattractant protein-1.
Kuna P; Reddigari SR; Rucinski D; Schall TJ; Kaplan AP
J Allergy Clin Immunol; 1995 Feb; 95(2):574-86. PubMed ID: 7531729
[TBL] [Abstract][Full Text] [Related]
6. Monocyte chemotactic and activating factor is a potent histamine-releasing factor for human basophils.
Kuna P; Reddigari SR; Rucinski D; Oppenheim JJ; Kaplan AP
J Exp Med; 1992 Feb; 175(2):489-93. PubMed ID: 1370686
[TBL] [Abstract][Full Text] [Related]
7. [The effect of loratadine on skin and bronchial reactivity and histamine liberation from basophils in patients with atopic asthma and allergic rhinitis].
Siergiejko Z; Michalska I; Buko Z; Swiderska M; Chyrek-Borowska S
Pneumonol Alergol Pol; 1994; 62(11-12):583-8. PubMed ID: 7536515
[TBL] [Abstract][Full Text] [Related]
8. Interleukin-8 and RANTES inhibit basophil histamine release induced with monocyte chemotactic and activating factor/monocyte chemoattractant peptide-1 and histamine releasing factor.
Alam R; Forsythe PA; Lett-Brown MA; Grant JA
Am J Respir Cell Mol Biol; 1992 Oct; 7(4):427-33. PubMed ID: 1382479
[TBL] [Abstract][Full Text] [Related]
9. [The effect of heparin on eosinophil chemotaxis induced by Rantes and FMLP].
Antczak-Marczak M; Kuna P
Pneumonol Alergol Pol; 1997; 65(9-10):588-96. PubMed ID: 9489431
[TBL] [Abstract][Full Text] [Related]
10. Histamine-releasing activity in supernatants of mononuclear cells: contribution of monocyte chemotactic protein-1 activity compared with IgE-dependent activity.
Pasmans SG; Aalbers M; Daha MR; Knol EF; Jansen HM; Aalberse RC
J Allergy Clin Immunol; 1996 Nov; 98(5 Pt 1):962-8. PubMed ID: 8939160
[TBL] [Abstract][Full Text] [Related]
11. Monocyte chemotactic and activating factor/monocyte chemoattractant protein-1-mediated histamine release from human nasal mucosa.
Fujikura T; Otsuka H
Arch Otolaryngol Head Neck Surg; 1998 Dec; 124(12):1331-5. PubMed ID: 9865755
[TBL] [Abstract][Full Text] [Related]
12. The human recombinant c-kit receptor ligand, rhSCF, induces mediator release from human cutaneous mast cells and enhances IgE-dependent mediator release from both skin mast cells and peripheral blood basophils.
Columbo M; Horowitz EM; Botana LM; MacGlashan DW; Bochner BS; Gillis S; Zsebo KM; Galli SJ; Lichtenstein LM
J Immunol; 1992 Jul; 149(2):599-608. PubMed ID: 1378071
[TBL] [Abstract][Full Text] [Related]
13. Monocyte chemotactic protein-2, monocyte chemotactic protein-3, and fibroblast-induced cytokine. Three new chemokines induce chemotaxis and activation of basophils.
Alam R; Forsythe P; Stafford S; Heinrich J; Bravo R; Proost P; Van Damme J
J Immunol; 1994 Oct; 153(7):3155-9. PubMed ID: 7522251
[TBL] [Abstract][Full Text] [Related]
14. The in vitro and in vivo effect of corticosteroids on basophil releasability in patients with mild and severe bronchial asthma.
Kivity S; Onn A; Agami O; Fireman E
Clin Exp Allergy; 1997 Aug; 27(8):909-14. PubMed ID: 9291288
[TBL] [Abstract][Full Text] [Related]
15. Effect of montelukast on basophil releasability in patients with asthma.
Sade K; Kivity S; Fireman E; Schwartz Y; Kivity S
Isr Med Assoc J; 2005 Dec; 7(12):792-5. PubMed ID: 16382702
[TBL] [Abstract][Full Text] [Related]
16. Pharmacologic study of basophil histamine release induced by monocyte chemotactic protein-1 with kinase inhibitors.
Suzuki M; Hirai K; Kitani S; Takaishi T; Kihara H; Kasahara T; Ito K; Morita Y
Int Arch Allergy Immunol; 1996 Sep; 111(1):18-22. PubMed ID: 8753839
[TBL] [Abstract][Full Text] [Related]
17. In vitro and in vivo effect of salbutamol on histamine release from human basophils.
Chazan R; Walajtys-Rode E; Grubek-Jaworska H; Madalinska M; Droszcz W
Int J Clin Pharmacol Ther Toxicol; 1991 Jan; 29(1):9-13. PubMed ID: 1706328
[TBL] [Abstract][Full Text] [Related]
18. Comparative ultrastructural morphology of human basophils stimulated to release histamine by anti-IgE, recombinant IgE-dependent histamine-releasing factor, or monocyte chemotactic protein-1.
Dvorak AM; Schroeder JT; MacGlashan DW; Bryan KP; Morgan ES; Lichtenstein LM; MacDonald SM
J Allergy Clin Immunol; 1996 Aug; 98(2):355-70. PubMed ID: 8757213
[TBL] [Abstract][Full Text] [Related]
19. Mechanisms of autoimmune activation of basophils in chronic urticaria.
Kikuchi Y; Kaplan AP
J Allergy Clin Immunol; 2001 Jun; 107(6):1056-62. PubMed ID: 11398085
[TBL] [Abstract][Full Text] [Related]
20. Monocyte chemotactic and activating factor/monocyte chemoattractant protein (MCAF/MCP-1) in bronchoalveolar lavage fluid from patients with atopic asthma and chronic bronchitis.
Jahnz-Rózyk KM; Kuna P; Pirozyńska E
J Investig Allergol Clin Immunol; 1997; 7(4):254-9. PubMed ID: 9330191
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
